Martin Haluzı́k
0000-0002-0201-6888
Publication & Citation Trends
Publications
535 total
789-P: Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) according to Prior Insulin Use
Cited by 0
Semantic Scholar
37-OR: SGLT2 Inhibitors Exert Anti-inflammatory and Antioxidant Effects in Epicardial Adipose Tissue of Severe Heart Failure Subjects
Cited by 0
Semantic Scholar
247-OR: Positive Effects of Bariatric Surgery Are Associated with Attenuation of Cellular Senescence
Cited by 0
Semantic Scholar
Non-altered incretin secretion in women with impaired fasting plasma glucose in the early stage of pregnancy: a case control study OA
Cited by 3
Semantic Scholar
800-P: Predictors of HbA1c and dTIR Responses with iGlarLixi in Type 2 Diabetes—Patient-Level Exploratory Analyses of the LixiLan-L Trial
Cited by 0
Semantic Scholar
Obesity pharmacotherapy - update 2023.
Cited by 2
Semantic Scholar
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide OA
Cited by 15
Semantic Scholar
906-P: Audit of Technologies Used for Glucose Monitoring and Insulin Delivery in Patients with Type 1 Diabetes at a Single Diabetes Center during 2019–2022—Real-World Data
Cited by 0
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(108)
Adipokines, Inflammation, and Metabolic Diseases
(92)
Adipose Tissue and Metabolism
(85)
Regulation of Appetite and Obesity
(84)
Diabetes Management and Research
(80)
Affiliations
Mount Sinai Beth Israel
National Institutes of Health
Apple (Israel)
Nanchang University
University of Ostrava